Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy

Detalhes bibliográficos
Autor(a) principal: Santos, Júlia Mariá Azambuja
Data de Publicação: 2022
Outros Autores: Lorenzzoni, Ana Maria Vieira, Tigre, Aline, Heldt, Elizeth
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
DOI: 10.32635/2176-9745.RBC.2022v68n1.1557
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1557
Resumo: Introduction: The ability to cope with adverse situations, defined as resilience, helps patients to overcome difficulties in their treatment. However, there are still few studies assessing resilience in cancer patients undergoing outpatient chemotherapy. Objective: To assess resilience in cancer patients undergoing outpatient chemotherapy and to verify its correlation with defense mechanisms, as well as with symptoms of depression and anxiety. Method: Observational, correlational and prospective study with patients of both sexes, diagnosed with cancer, over 18 years old, literate and beginning treatment with outpatient chemotherapy. The following instruments were applied on the first day of chemotherapy treatment and then again after 30 to 45 days: Resilience Scale, Defense Style Questionnaire (DSQ-40), Beck’s Depression Inventory and Beck’s Anxiety Inventory. Results: A total of 55 participants were included in the study, 32 (58%) of which were female, with an average age and standard deviation (SD) of 54.1 (SD=12.2) years. The most frequent diagnoses were colorectal cancer, 15 (27%) and breast cancer, 12 (22%). There was a significant negative correlation between symptoms of depression or anxiety and resilience levels both in the first (p<0.001) and in the second evaluation (p<0.05). Mature defense mechanisms (mood and rationalization) showed a significant positive correlation with resilience, while immature ones (performance and split) showed a negative correlation. Conclusion: The results confirmed that a greater capacity for resilience correlates with the use of adaptive defense mechanisms and with lower levels of depressive symptoms and anxiety in patients while receiving outpatient chemotherapy.
id INCA-1_c8d5abede893d21062f9c40f2e42d72f
oai_identifier_str oai:rbc.inca.gov.br:article/1557
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
spelling Resilience and Defense Mechanisms in Patients with Cancer Outpatient ChemotherapyResiliencia y Mecanismos de Defensa en Pacientes con Cáncer en Quimioterapia AmbulatorialResiliência e Mecanismos de Defesa em Pacientes com Câncer em Quimioterapia Ambulatorialresiliência psicológicaneoplasiastratamento farmacológicomecanismos de defesaresilience, psychologicalneoplasmsdrug therapydefense mechanismsresiliencia psicológicaneoplasiasquimioterapiamecanismos de defensaIntroduction: The ability to cope with adverse situations, defined as resilience, helps patients to overcome difficulties in their treatment. However, there are still few studies assessing resilience in cancer patients undergoing outpatient chemotherapy. Objective: To assess resilience in cancer patients undergoing outpatient chemotherapy and to verify its correlation with defense mechanisms, as well as with symptoms of depression and anxiety. Method: Observational, correlational and prospective study with patients of both sexes, diagnosed with cancer, over 18 years old, literate and beginning treatment with outpatient chemotherapy. The following instruments were applied on the first day of chemotherapy treatment and then again after 30 to 45 days: Resilience Scale, Defense Style Questionnaire (DSQ-40), Beck’s Depression Inventory and Beck’s Anxiety Inventory. Results: A total of 55 participants were included in the study, 32 (58%) of which were female, with an average age and standard deviation (SD) of 54.1 (SD=12.2) years. The most frequent diagnoses were colorectal cancer, 15 (27%) and breast cancer, 12 (22%). There was a significant negative correlation between symptoms of depression or anxiety and resilience levels both in the first (p<0.001) and in the second evaluation (p<0.05). Mature defense mechanisms (mood and rationalization) showed a significant positive correlation with resilience, while immature ones (performance and split) showed a negative correlation. Conclusion: The results confirmed that a greater capacity for resilience correlates with the use of adaptive defense mechanisms and with lower levels of depressive symptoms and anxiety in patients while receiving outpatient chemotherapy.Introducción: La capacidad de afrontar situaciones adversas, que se define como resiliencia, ayuda al paciente a superar las dificultades del tratamiento. Sin embargo, todavía hay pocos estudios que evalúen la resiliencia en pacientes con cáncer sometidos a quimioterapia ambulatoria. Objetivo: Evaluar la resiliencia de los pacientes oncológicos sometidos a quimioterapia ambulatoria y verificar la correlación con los mecanismos de defensa y con síntomas depresivos o de ansiedad. Método: Estudio observacional, correlacional y prospectivo con pacientes de ambos sexos, diagnosticados con cáncer, mayores de 18 años, alfabetizados e iniciando tratamiento con quimioterapia ambulatoria. Los siguientes instrumentos se aplicaron el primer día de tratamiento de quimioterapia y otra vez después de 30 a 45 días: Escala de resiliencia, Cuestionario de estilo de defensa (DSQ-40), Inventario de depresión de Beck e Inventario de ansiedad de Beck. Resultados: Se incluyeron 55 participantes en la investigación, 32 (58%) de los cuales eran mujeres, con una edad promedio y desviación estándar (DE) de 54,1 (DE=12,2) anos. Los diagnósticos más frecuentes fueron cáncer colorrectal, 15 (27%) y cáncer de mama, 12 (22%). Se encontró una correlación negativa significativa entre síntomas depresivos o de ansiedad y los niveles de resiliencia tanto en la primera (p<0,001) como en la segunda evaluación (p<0,05). Los mecanismos de defensa maduros (estado de ánimo y racionalización) mostraron una correlación positiva significativa y los inmaduros (rendimiento y división) mostraron una correlación negativa. Conclusión: Los resultados confirmaron que una mayor capacidad de resiliencia se correlaciona con el uso de mecanismos de defensa adaptativos y con menores niveles de síntomas depresivos y ansiedad en pacientes durante la quimioterapia ambulatoria.Introdução: A capacidade de enfrentamento de situações adversas, que e definida como resiliência, auxilia o paciente a superar as dificuldades do tratamento. Entretanto, ainda são poucos os estudos que avaliam a resiliência em pacientes com câncer que realizam quimioterapia ambulatorial. Objetivo: Avaliar a resiliência de pacientes com câncer em tratamento quimioterápico ambulatorial e verificar a correlação com os mecanismos de defesa, sintomas depressivos e de ansiedade. Método: Estudo observacional, de correlação e prospectivo, com pacientes com diagnostico de câncer, de ambos os sexos, maiores de 18 anos, alfabetizados e em início de tratamento com quimioterapia ambulatorial. Os seguintes instrumentos foram aplicados no primeiro dia de tratamento quimioterápico e após 30 a 45 dias: Escala de Resiliência, Defense Style Questionnaire (DSQ-40), Inventario de Depressão de Beck e Inventario de Ansiedade de Beck. Resultados: Um total de 55 participantes foi incluído, sendo 32 (58%) do sexo feminino, com média e desvio-padrão (DP) de idade de 54,1 (DP=12,2) anos. Os diagnósticos mais frequentes foram câncer colorretal, 15 (27%) e câncer de mama, 12 (22%). Observou-se correlação negativa significativa entre sintomas depressivos e de ansiedade com os níveis de resiliência tanto na primeira (p<0,001) como na segunda avaliação (p<0,05). Os mecanismos de defesa maduros (humor e racionalização) apresentaram correlação positiva significativa e os imaturos (atuação e cisão) demonstraram correlação negativa. Conclusão: Os resultados confirmaram que a maior capacidade de resiliência se correlaciona com o uso de mecanismos de defesa adaptativos e com menores níveis de sintomas depressivos e de ansiedade em pacientes durante a quimioterapia ambulatorial.INCA2022-02-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/155710.32635/2176-9745.RBC.2022v68n1.1557Revista Brasileira de Cancerologia; Vol. 68 No. 1 (2022): Jan./Feb./Mar.; e-131557Revista Brasileira de Cancerologia; Vol. 68 Núm. 1 (2022): ene./feb./mar.; e-131557Revista Brasileira de Cancerologia; v. 68 n. 1 (2022): jan./fev./mar.; e-1315572176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/1557/1580https://rbc.inca.gov.br/index.php/revista/article/view/1557/1923https://rbc.inca.gov.br/index.php/revista/article/view/1557/2390Copyright (c) 2022 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Júlia Mariá Azambuja Lorenzzoni, Ana Maria Vieira Tigre, AlineHeldt, Elizeth 2022-11-25T18:35:50Zoai:rbc.inca.gov.br:article/1557Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2022-11-25T18:35:50Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
Resiliencia y Mecanismos de Defensa en Pacientes con Cáncer en Quimioterapia Ambulatorial
Resiliência e Mecanismos de Defesa em Pacientes com Câncer em Quimioterapia Ambulatorial
title Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
spellingShingle Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
Santos, Júlia Mariá Azambuja
resiliência psicológica
neoplasias
tratamento farmacológico
mecanismos de defesa
resilience, psychological
neoplasms
drug therapy
defense mechanisms
resiliencia psicológica
neoplasias
quimioterapia
mecanismos de defensa
Santos, Júlia Mariá Azambuja
resiliência psicológica
neoplasias
tratamento farmacológico
mecanismos de defesa
resilience, psychological
neoplasms
drug therapy
defense mechanisms
resiliencia psicológica
neoplasias
quimioterapia
mecanismos de defensa
title_short Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
title_full Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
title_fullStr Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
title_full_unstemmed Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
title_sort Resilience and Defense Mechanisms in Patients with Cancer Outpatient Chemotherapy
author Santos, Júlia Mariá Azambuja
author_facet Santos, Júlia Mariá Azambuja
Santos, Júlia Mariá Azambuja
Lorenzzoni, Ana Maria Vieira
Tigre, Aline
Heldt, Elizeth
Lorenzzoni, Ana Maria Vieira
Tigre, Aline
Heldt, Elizeth
author_role author
author2 Lorenzzoni, Ana Maria Vieira
Tigre, Aline
Heldt, Elizeth
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, Júlia Mariá Azambuja
Lorenzzoni, Ana Maria Vieira
Tigre, Aline
Heldt, Elizeth
dc.subject.por.fl_str_mv resiliência psicológica
neoplasias
tratamento farmacológico
mecanismos de defesa
resilience, psychological
neoplasms
drug therapy
defense mechanisms
resiliencia psicológica
neoplasias
quimioterapia
mecanismos de defensa
topic resiliência psicológica
neoplasias
tratamento farmacológico
mecanismos de defesa
resilience, psychological
neoplasms
drug therapy
defense mechanisms
resiliencia psicológica
neoplasias
quimioterapia
mecanismos de defensa
description Introduction: The ability to cope with adverse situations, defined as resilience, helps patients to overcome difficulties in their treatment. However, there are still few studies assessing resilience in cancer patients undergoing outpatient chemotherapy. Objective: To assess resilience in cancer patients undergoing outpatient chemotherapy and to verify its correlation with defense mechanisms, as well as with symptoms of depression and anxiety. Method: Observational, correlational and prospective study with patients of both sexes, diagnosed with cancer, over 18 years old, literate and beginning treatment with outpatient chemotherapy. The following instruments were applied on the first day of chemotherapy treatment and then again after 30 to 45 days: Resilience Scale, Defense Style Questionnaire (DSQ-40), Beck’s Depression Inventory and Beck’s Anxiety Inventory. Results: A total of 55 participants were included in the study, 32 (58%) of which were female, with an average age and standard deviation (SD) of 54.1 (SD=12.2) years. The most frequent diagnoses were colorectal cancer, 15 (27%) and breast cancer, 12 (22%). There was a significant negative correlation between symptoms of depression or anxiety and resilience levels both in the first (p<0.001) and in the second evaluation (p<0.05). Mature defense mechanisms (mood and rationalization) showed a significant positive correlation with resilience, while immature ones (performance and split) showed a negative correlation. Conclusion: The results confirmed that a greater capacity for resilience correlates with the use of adaptive defense mechanisms and with lower levels of depressive symptoms and anxiety in patients while receiving outpatient chemotherapy.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1557
10.32635/2176-9745.RBC.2022v68n1.1557
url https://rbc.inca.gov.br/index.php/revista/article/view/1557
identifier_str_mv 10.32635/2176-9745.RBC.2022v68n1.1557
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1557/1580
https://rbc.inca.gov.br/index.php/revista/article/view/1557/1923
https://rbc.inca.gov.br/index.php/revista/article/view/1557/2390
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 68 No. 1 (2022): Jan./Feb./Mar.; e-131557
Revista Brasileira de Cancerologia; Vol. 68 Núm. 1 (2022): ene./feb./mar.; e-131557
Revista Brasileira de Cancerologia; v. 68 n. 1 (2022): jan./fev./mar.; e-131557
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1822182051175989248
dc.identifier.doi.none.fl_str_mv 10.32635/2176-9745.RBC.2022v68n1.1557